0001723443-26-000008.txt : 20261110 0001723443-26-000008.hdr.sgml : 20261110 20261110164035 ACCESSION NUMBER: 0001723443-26-000008 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261110 DATE AS OF CHANGE: 20261110 EFFECTIVENESS DATE: 20261110 FILER: COMPANY DATA: COMPANY CONFORMED NAME: InSitu Biologics, Inc. CENTRAL INDEX KEY: 0001723443 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 823415514 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-501108 FILM NUMBER: 261541132 BUSINESS ADDRESS: STREET 1: 3510 HOPKINS PLACE N. STREET 2: BUILDING 4 CITY: OAKDALE STATE: MN ZIP: 55128 BUSINESS PHONE: 651-337-4799 MAIL ADDRESS: STREET 1: 3510 HOPKINS PLACE N. STREET 2: BUILDING 4 CITY: OAKDALE STATE: MN ZIP: 55128 FORMER COMPANY: FORMER CONFORMED NAME: InSitu Biologics, Inc DATE OF NAME CHANGE: 20171121 D/A 1 primary_doc.xml X0708 D/A LIVE 0001723443 InSitu Biologics, Inc. 3510 HOPKINS PLACE N. BUILDING 4 OAKDALE MN MINNESOTA 55128 651-337-4799 DELAWARE InSitu Biologics, Inc Corporation true Daniel Halpern 3510 Hopkins Place Building 4 Oakdale MN MINNESOTA 55128 Executive Officer Director William Taylor 3510 Hopkins Place Building 4 Oakdale MN MINNESOTA 55128 Executive Officer Sandi Klemann 3510 Hopkins Place Building 4 Oakdale MN MINNESOTA 55128 Executive Officer Robert Wilson 3510 Hopkins Place Building 4 Oakdale MN MINNESOTA 55128 Director Greg Van Guilder 3510 Hopkins Place Building 4 Oakdale MN MINNESOTA 55128 Director Ivan Shaw 3510 Hopkins Place Building 4 Oakdale MN MINNESOTA 55128 Director Biotechnology Decline to Disclose 06b true 0001790300-23-000004 2022-10-14 true true true true false 1850 19837423 15037850 4799573 $4,799,573 represents the aggregate exercise price to exercise in cash all warrants issued in the offering, calculated at the exercise prices currently in effect. false 27 0 0 0 Excludes ordinary course compensation paid to officers. false InSitu Biologics, Inc. /s/ Daniel Halpern Daniel Halpern Chief Executive Officer 2026-10-26